Tarsus Pharmaceuticals, Inc. (TARS)

Last Closing Price: 49.36 (2025-09-12)

Weighted-Average Shares Outstanding (Diluted) (Annual)

Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.

Tarsus Pharmaceuticals, Inc. (TARS) had Weighted-Average Shares Outstanding (Diluted) of 37.60M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$182.95M
$-115.55M
$12.83M
$170.13M
$303.52M
$-120.57M
$5.01M
$-115.55M
$-115.55M
$-115.55M
$-115.55M
$-115.55M
$-115.55M
$-120.57M
$-123.08M
37.60M
Weighted-Average Shares Outstanding (Diluted)
37.60M
$-3.07
$-3.07
Balance Sheet Financials
$356.70M
$2.31M
$20.29M
$376.99M
$80.61M
$71.84M
$71.84M
$152.46M
$224.53M
$216.21M
$224.53M
38.35M
Cash Flow Statement Financials
$-83.03M
$-199.19M
$154.66M
$224.95M
$97.38M
$-127.57M
$27.82M
--
--
Fundamental Metrics & Ratios
4.42
--
--
0.24
0.32
92.99%
-65.90%
-65.90%
-67.27%
-63.16%
-63.16%
$-84.59M
--
--
--
0.49
4.90
3.81
95.88
-51.46%
-53.45%
-30.65%
-38.99%
$5.85
$-2.25
$-2.21